UPB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Upstream Bio Inc (UPB) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has shown improvement in financial performance, the lack of strong trading signals, neutral sentiment from hedge funds and insiders, and no significant positive catalysts suggest holding off on immediate investment. Additionally, the technical indicators and options data do not strongly support a bullish move.
The MACD is positive and contracting, indicating a potential slowdown in bullish momentum. The RSI is neutral at 36.813, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are S1: 7.753 and R1: 9.663, with the current pre-market price at 8.395, sitting below the pivot level of 8.708.
The company's financials show YoY improvement in revenue (+12.52%), net income (+60.45%), and EPS (+53.66%), indicating growth trends. Gross margin remains strong at 100%.
No recent news or significant trading trends from hedge funds or insiders. Congress trading data is unavailable. Technical indicators and options data do not provide strong bullish signals.
In Q3 2025, revenue increased to $683,000 (+12.52% YoY). Net income improved but remains negative at -$33.75M (+60.45% YoY). EPS increased to -0.63 (+53.66% YoY). Gross margin is stable at 100%.
No analyst rating or price target data available.
